Date published: 2026-5-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

FBL3B Inhibitors

FBL3B inhibitors belong to a distinctive class of chemical compounds designed to modulate the activity of the FBL3B enzyme. FBL3B, or F-box and leucine-rich repeat protein 3B, is a crucial component of the SCF (Skp1-Cullin-F-box) ubiquitin ligase complex. This complex plays a pivotal role in the ubiquitin-proteasome system, which regulates the degradation of intracellular proteins. FBL3B, as an F-box protein, acts as the substrate recognition module within this complex, facilitating the specific targeting of proteins for ubiquitination and subsequent degradation. Inhibitors of FBL3B aim to interfere with this regulatory mechanism, disrupting the targeted degradation of specific proteins and influencing cellular processes that rely on the precise control of protein levels. FBL3B inhibitors are meticulously designed to interact with the active site or binding pocket of the FBL3B enzyme, obstructing its normal function. These inhibitors can adopt various structural motifs, including small molecules or peptidomimetics, tailored to fit the specific requirements of inhibiting FBL3B's substrate recognition and ubiquitin ligase activity. Understanding the structural nuances and binding interactions of these inhibitors is critical for elucidating their mode of action and potential applications in modulating cellular pathways.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A peptide aldehyde that can inhibit proteasome and calpain activities, thereby potentially affecting the degradation of proteins targeted by FBXL21.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A boronic acid derivative that inhibits the 26S proteasome, which may indirectly affect the function of FBXL21 in protein ubiquitination.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

A naturally occurring compound that irreversibly inhibits proteasome activity, thus could affect the turnover of proteins regulated by FBXL21.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

A selective proteasome inhibitor that could alter the degradation pathway of substrates tagged by FBXL21.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

An epoxyketone-based proteasome inhibitor that could disrupt the degradation of FBXL21-labeled proteins.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

An oral proteasome inhibitor that, by inhibiting the proteasome, could potentially alter the activity of FBXL21.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

A small-molecule proteasome inhibitor that could affect the degradation of proteins involved in the FBXL21 pathway.

Delanzomib, free base

847499-27-8sc-396774
sc-396774A
5 mg
10 mg
$160.00
$300.00
(0)

A proteasome inhibitor that could influence the ubiquitin-proteasome system and thereby the function of FBXL21.